Concepedia

Mohammed A. Dahab

MA

Statistics

Publications

22

Citations

1.2K

H-Index

18

Active since

2020

Affiliations

Al-Azhar University(Current)

Almaarefa University

Princess Nourah bint Abdulrahman University

Alfaisal University

Cairo University

Mohammed A. Dahab is an author at Al-Azhar University specializing in drug discovery, medicinal chemistry, and drug design.

ORCID

Publications per year

2020–2024

22

Publications

22

Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor

Ahmed A. Al‐Karmalawy, Mohammed A. Dahab, Ahmed M. Metwaly et al. · Frontiers in Chemistry · 2021 · 275 citations · Full text

, , +17

New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and <i>in silico</i> studies

Hazem Elkady, Alaa Elwan, Hesham A. El‐Mahdy et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2021 · 122 citations · Full text

, , +14

New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis

Nawaf A. Alsaif, Mohammed A. Dahab, Mohammed M. Alanazi et al. · Bioorganic Chemistry · 2021 · 105 citations

, , +17

New bis([1,2,4]triazolo)[4,3-a:3′,4′-c]quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation

Mohammed M. Alanazi, Hazem A. Mahdy, Nawaf A. Alsaif et al. · Bioorganic Chemistry · 2021 · 96 citations

, , +15

New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with <i>in silico</i> docking, ADMET, toxicity, and DFT studies

Mohammed M. Alanazi, Hazem Elkady, Nawaf A. Alsaif et al. · RSC Advances · 2021 · 68 citations · Full text

, , +13

1–5 of 22